BTIG analyst Ryan Zimmerman upgraded Treace Medical (TMCI) to Buy from Neutral with a $16 price target The company has pivoted away from ...

Treace Medical Concepts (TMCI) is jumping 7.5% after investment bank BTIG upgraded the shares to Buy from Neutral. Why BTIG ...

Treace has pioneered and patented the Lapiplasty® 3D Bunion Correction® System – a combination of instruments, implants, and surgical methods designed to surgically correct all three planes of ...

It also supports the healing process with a unique fixation method that complements Treace's existing Lapiplasty and Adductoplasty procedures. "We're excited to expand our best-in-class bunion ...

Treace Medical Concepts, Inc. engages in the design, manufacture, and marketing of orthopedic medical devices and biologic solutions. It offers Lapiplasty, a bunion surgery for three-dimensional ...

Jan. 13, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts ... of bunions and related midfoot deformities through its flagship Lapiplasty ® and Adductoplasty ® Procedures, today announced ...

citing “increased use of MIS Osteotomy solutions and more competition from knockoffs of [the Company’s] Lapiplasty products.” On this news, Treace’s stock price fell $6.95, or 62.5% ...

Treace Medical Concepts, Inc. has announced the limited market release of its new Percuplasty™ Percutaneous 3D Bunion Correction® System, following successful initial surgical cases. This ...

Jan. 02, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts ... bunions and related midfoot deformities through its flagship Lapiplasty® and Adductoplasty® Procedures, today announced that ...